- Citations, last 5 years
- 34.1k
- Works, last 5 years
- 1 655
- h-index
- 548
- Scientists listed
- 0
- Grants since 2016
- 573
Grants received
2019–2024 · program · P01
Combinatorial Regulation of Gene Networks During Cardiac Development and Disease
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2019–2021 · research · R61
Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · research · R01
Deciphering molecular pathways of inhibitory interneuron dysfunction in Alzheimer's disease
Jorge J Palop · Gladstone Institutes · funded by National Institutes of Health
2019–2023 · career development · K99
Functional Alterations of Parvalbumin Interneurons Contributing to Abnormal Network Activity in Alzheimer's Disease Mouse Models
Keran Ma · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · research · RF1
Neural network and immune cell dysfunctions in Alzheimer's disease pathogenesis
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · research · R01
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral Organoids
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2019–2022 · fellowship · F32
Bioenergetic and Proteolytic Impact of Ubiquitin-like Pathways in Metabolically Stressed Neurons
Neal Bennett · Gladstone Institutes · funded by National Institutes of Health
2019–2021 · fellowship · F32
Evaluation and Disruption of Tau - GSK3ò Vicious Cycle
Daniel Gulbranson · Gladstone Institutes · funded by National Institutes of Health
2019–2022 · fellowship · F32
Evaluation and Disruption of Tau - GSK3β Vicious Cycle
Daniel Gulbranson · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Core C: Genome Engineering Core
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Project 2: Regulation of cardiac gene regulation and differentiation by dynamic chromatin remodeling complexes
Benoit Gaetan Bruneau · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Core B: Advanced Bioinformatics Core
Katherine S. Pollard · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Administrative Core
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Administrative Core
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Project 3: Control of cardiac transcription by MEF2 and myocardin
Brian L Black · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Core A: Advanced Proteomics Core
Nevan J Krogan · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Core A: Advanced Proteomics Core
Nevan J Krogan · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Project 2: Regulation of cardiac gene regulation and differentiation by dynamic chromatin remodeling complexes
Benoit Gaetan Bruneau · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Core B: Advanced Bioinformatics Core
Katherine S. Pollard · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Core C: Genome Engineering Core
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Project 3: Control of cardiac transcription by MEF2 and myocardin
Brian L Black · Gladstone Institutes · funded by National Institutes of Health
2019–2025 · program · P01
Project 1: Regulation of gene networks through cardiac transcription factor interaction with the nuclear membrane
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2019–2024 · program · P01
Project 1: Regulation of gene networks through cardiac transcription factor interaction with the nuclear membrane
Deepak Srivastava · Gladstone Institutes · funded by National Institutes of Health
2018–2024 · research · R01
Therapeutic Potential and Mechanisms of Tau Reduction in Autism Models
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · RF1
Optogenetic dissection of cellular and circuit mechanisms of network dysfunction and amyloid deposition in mouse models of Alzheimer's disease in vivo
Jorge J Palop · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · R00
Functional characterization of the Alzheimer's disease Epigenome
Michael Ryan Corces · Gladstone Institutes · funded by National Institutes of Health
2018–2021 · research · R61
Harnessing the RNA-Binding Properties of Cas13a for HIV-1 Self-Testing
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2018–2020 · research · R56
Apolipoprotein E and Alzheimer's Disease: Mitochondrial Dysfunction and Neurodegeneration
Robert W. Mahley · Gladstone Institutes · funded by National Institutes of Health
2018–2020 · career development · K99
Role of Dopamine and Basal Ganglia Circuits in Integrating Costs and Benefits for Action
Christopher H Donahue · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
Todd C Mcdevitt · Gladstone Institutes · funded by National Institutes of Health
2018 · research · AARF
Role of Tau in modulating neural activity in Alzheimer’s disease
Che-Wei Chang · Gladstone Institutes · funded by Alzheimer's Association
2018–2023 · research · R00
Functional characterization of the Alzheimer's disease Epigenome
Michael Ryan Corces · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
Todd C Mcdevitt · Gladstone Institutes · funded by National Institutes of Health
2018–2021 · research · R61
Harnessing the RNA-Binding Properties of Cas13a for HIV-1 Self-Testing
Melanie Maria Ott · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2018–2020 · fellowship · Postdoctoral Fellowship
Nuclear pore interaction with cardiac transcription factors during cardiomyocyte differentiation
Barbara Gonzalez Teran · Gladstone Institutes · funded by American Heart Association
2018–2023 · cooperative agreement · U01
JAX-Gladstone, SCGE Disease Models Studies Supplement
Bruce R Conklin · Gladstone Institutes · funded by National Institutes of Health
2018–2021 · research · RF1
Discovery of Novel Drugs that Increase Tau Clearance to Treat Alzheimer's Disease
Steven M Finkbeiner · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Potential and Mechanisms of Tau Reduction in Autism Models
Lennart Mucke · Gladstone Institutes · funded by National Institutes of Health
2018–2023 · research · R00
Functional characterization of the Alzheimer's disease Epigenome
Michael Ryan Corces · Gladstone Institutes · funded by National Institutes of Health